Literature DB >> 11390630

Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in Brazilian women.

S S Witkin1, I M Linhares, S Gerber, M E Caetano, A C Segurado.   

Abstract

Interleukin-1 receptor antagonist (IL-1ra) gene polymorphisms in 83 human immunodeficiency virus (HIV)-seropositive women were evaluated. Fourteen of the subjects (16.9%) were homozygous for IL-1ra allele 2 (IL-1RN*2). These women had a lower median level of HIV RNA than did women homozygous for allele 1 (IL-1RN*1) (P = 0.01) or heterozygous for both alleles (P = 0.04). Among 46 subjects not receiving antiretroviral treatment, HIV levels were also reduced in IL-1RN*2 homozygous individuals (P < 0.05). There was no relation between IL-1ra alleles and CD4 levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390630      PMCID: PMC114344          DOI: 10.1128/JVI.75.13.6242-6244.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population.

Authors:  R Bellamy; D Kwiatkowski; A V Hill
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 May-Jun       Impact factor: 2.184

Review 2.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

3.  Relationship between Ureaplasma urealyticum vaginal colonization and polymorphism in the interleukin-1 receptor antagonist gene.

Authors:  J Jeremias; P Giraldo; S Durrant; A Ribeiro-Filho; S S Witkin
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

4.  Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro.

Authors:  S Santtila; K Savinainen; M Hurme
Journal:  Scand J Immunol       Date:  1998-03       Impact factor: 3.487

5.  Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.

Authors:  M C Knuchel; T J Spira; A U Neumann; L Xiao; D L Rudolph; J Phair; S M Wolinsky; R A Koup; O J Cohen; T M Folks; R B Lal
Journal:  AIDS Res Hum Retroviruses       Date:  1998-03-01       Impact factor: 2.205

6.  Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies.

Authors:  L G Rider; C M Artlett; C B Foster; A Ahmed; T Neeman; S J Chanock; S A Jimenez; F W Miller
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

7.  Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes.

Authors:  M Hurme; M Helminen
Journal:  Scand J Infect Dis       Date:  1998

8.  Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.

Authors:  E V Granowitz; B M Saget; M Z Wang; C A Dinarello; P R Skolnik
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

Review 9.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

10.  Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells.

Authors:  D Goletti; A L Kinter; E C Hardy; G Poli; A S Fauci
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  5 in total

1.  Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection.

Authors:  Nicole Schmitz; Michael Kurrer; Martin F Bachmann; Manfred Kopf
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level.

Authors:  J Sainz; E Pérez; S Gómez-Lopera; M Jurado
Journal:  J Clin Immunol       Date:  2008-05-17       Impact factor: 8.317

3.  HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008.

Authors:  Hans-Jürgen Stellbrink; S Baldus; G Behrens; J R Bogner; T Harrer; C Hoffmann; J van Lunzen; J Münch; P Racz; C Scheller; M Stoll; K Tenner-Racz; J Rockstroh
Journal:  Eur J Med Res       Date:  2010-01-29       Impact factor: 2.175

4.  IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity.

Authors:  HariOm Singh; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

Review 5.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.

Authors:  Katrin D Mayer-Barber; Bo Yan
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.